PMA

P010040: THE DISINTEGRATOR INSULIN NEEDLE DESTRUCTION DEVICE

FDA PMA · Sharps needle destruction device · Redhawk Medical Products & Services, LLC

Key facts

PMA number P010040
Trade name THE DISINTEGRATOR INSULIN NEEDLE DESTRUCTION DEVICE
Generic name Sharps needle destruction device
Applicant Redhawk Medical Products & Services, LLC
Product code MTV
Approval date Mar 15, 2002
Docket number 02M-0118
Notice date Mar 22, 2002

At a glance

  • 1–9 Supplements
  • Apr 4, 2003 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals